Publication:
Estimating the burden of a-thalassaemia in Thailand using a comprehensive prevalence database for southeast Asia

dc.contributor.authorCarinna Hockhamen_US
dc.contributor.authorSupachai Ekwattanakiten_US
dc.contributor.authorSamir Bhatten_US
dc.contributor.authorBridget S. Penmanen_US
dc.contributor.authorSunetra Guptaen_US
dc.contributor.authorVip Viprakasiten_US
dc.contributor.authorFrédéric B. Pielen_US
dc.contributor.otherGeorge Institute for Global Healthen_US
dc.contributor.otherUniversity of Oxforden_US
dc.contributor.otherThe University of Warwicken_US
dc.contributor.otherImperial College Londonen_US
dc.contributor.otherFaculty of Medicine, Siriraj Hospital, Mahidol Universityen_US
dc.date.accessioned2020-01-27T07:45:26Z
dc.date.available2020-01-27T07:45:26Z
dc.date.issued2019-05-01en_US
dc.description.abstract© Hockham et al. Severe forms of a-thalassaemia, haemoglobin H disease and haemoglobin Bart’s hydrops fetalis, are an important public health concern in Southeast Asia. Yet information on the prevalence, genetic diversity and health burden of a-thalassaemia in the region remains limited. We compiled a geodatabase of a-thalassaemia prevalence and genetic diversity surveys and, using geostatistical modelling methods, generated the first continuous maps of a-thalassaemia mutations in Thailand and sub-national estimates of the number of newborns with severe forms in 2020. We also summarised the current evidence-base for a-thalassaemia prevalence and diversity for the region. We estimate that 3595 (95% credible interval 1,717–6,199) newborns will be born with severe a-thalassaemia in Thailand in 2020, which is considerably higher than previous estimates. Accurate, fine-scale epidemiological data are necessary to guide sustainable national and regional health policies for a-thalassaemia management. Our maps and newborn estimates are an important first step towards this aim. Editorial note: This article has been through an editorial process in which the authors decide how to respond to the issues raised during peer review. The Reviewing Editor’s assessment is that all the issues have been addressed (see decision letter).en_US
dc.identifier.citationeLife. Vol.8, (2019)en_US
dc.identifier.doi10.7554/eLife.40580en_US
dc.identifier.issn2050084Xen_US
dc.identifier.other2-s2.0-85066470558en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/50193
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85066470558&origin=inwarden_US
dc.subjectBiochemistry, Genetics and Molecular Biologyen_US
dc.subjectImmunology and Microbiologyen_US
dc.titleEstimating the burden of a-thalassaemia in Thailand using a comprehensive prevalence database for southeast Asiaen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85066470558&origin=inwarden_US

Files

Collections